Diabetes Care Products Market Analysis By Monitoring Device(Self-monitoring Blood Glucose Device, Continuous Glucose Monitoring Devices), By Management Device(Insulin Pump, Insulin Syringes, Cartridges in Reusable pens, Insulin Disposable Pens, Jet Injectors), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) & Forecast 2024-2035
- PUBLISHED ON
- 11/23/2022
- NO OF PAGES
- 229
- CATEGORY
- Healthcare & Life Sciences
The global diabetes care products market size was valued at USD 21.0 billion in 2021 and is projected to reach around USD 38.5 billion in 2030 exhibiting a CAGR of 6.5% in the forecasted period.
The upsurge in the prevalence of diabetes and a change in development & sedentary lifestyle. Additionally, technological developments in the diabetes devices, a growth in the diabetic population worldwide, a rise in the need for fast & safe analysis, and an increase in treatments for diabetes lead the diabetic care products market during the forecast period.
Rise in prevalence of diabetes due to obesity, aging, and unhealthy lifestyle is among the factors boosting the growth of the market. Obesity is a main factor leading to diabetes. As per the World Health Organization (WHO), in 2016, more than 1.9 billion adults were overweight, around 650 million people were obese. Risk factors, like obesity and overweight, are prominent factors for growth in the incidence of diabetes. Hence, risk factors such as overweight, smoking, obesity, and high cholesterol levels are expected to boost the prevalence of diabetes, thus fuelling the need for diabetes care products.
The number of people suffering from diabetes in regions such as MEA and APAC is rising, which in turn is boosting the demand for diabetes treatment. For instance, according to the International Diabetes Federation, in 2017, around 72,946,400 new cases of diabetes were detected in India. Thus, existence of untapped growth opportunities in speedily increasing MEA and Asian nations and rising awareness of diabetes in these nations are expected to boost the demand for diabetes devices.
COVID -19 impact remains positive on the diabetes care products market. This was due to patients with several health issues, containing diabetes and high blood pressure being at higher risk of being infected by this virus. The mortality rate was more in patients with diabetes related to the general population. People with diabetes need constant access to insulin and care. Therefore, the acceptance of insulin pens and uninterrupted glucose monitoring devices increased the demand for close monitoring and optimal management of diabetes.
Type Insights
Insulin delivery devices are known as the fastest growing segment in the global diabetes care products market and accounted for over 56% share in 2021. Based on insulin delivery device, the market has been categorised into pens, syringes, pumps, and jet injectors. Pens held a maximum share of the diabetes care products market in 2021. Though, the pump segment is anticipated to gain substantial market share as it is projected to grow at fastest CAGR during the forecast period.
Some of the lowest blood glucose meters with innovative technology present in the U.K. are Abbott Diabetes Care Freestyle Lite, Lifescan’s One Touch UltraEasy, Accu-Chek Mobile, Bayer’s CONTOUR NEXT USB, Accu-Chek Aviva Nano, & TRUEone blood glucose meter. The introduction of these small, discreet, and easy-to-use blood glucose meters is anticipated to boost segment growth across the forecasted period.
Continuous glucose monitoring (CGM) is said to further collaborate with insulin delivery systems to enable a single integrated system for effective diabetes care management. For instance, Tandem Diabetes Care launched its Slim X2 insulin pump, which is incorporated with Dexcom G6 CGM. Likewise, Ypsomed Holdings developed a CGM system called Mylife Unio Neva, which assimilates with the company’s insulin pump.
Distribution Channel Insights
In 2021, hospital pharmacies dominated with more than 54.0% of the market diffusion due to high pace and accessibility of products. The two types of drugstores operating within a hospital campus are inpatient pharmacy and outpatient pharmacy. Inpatient pharmacy is within the hospital, available only by authorized personnel serving operation rooms, inpatient wards, ICU, and special service areas. However, outpatient pharmacies are normally located in hospital lobbies and entries for customers. Handheld glucose meters and insulin delivery devices are present at the outpatient pharmacy.
As online pharmacies directly procure diabetes devices from the manufacturers, it assists them avail profitable deals for customers. The rising patient awareness about online pharmacies and better public-private funding are major factors boosting the segment. The COVID-19 pandemic has certainly impacted the e-pharmacies business; the sales volume of diabetes devices is witnessed to have increased through this platform.
Region Insights
North America lead the market in 2021 and is anticipated to dominate the market with a growth rate of over 6.0% CAGR during the forecast period due to its well-established healthcare sector. The rising prevalence of obesity and the high cost of treatment is also anticipated to boost the region, along with technological developments and new product launches.
In North America, the U.S. lead the market due to a large diabetic population and favourable reimbursement policies. High per capita revenue and growing healthcare spending are amongst the key factors propelling its market. As per the American Diabetes Association, in 2019, the average projected cost of diabetes-specific treatments per person was USD 9,505.60. In the U.S., a diabetic patient can experience an overall medical spending of around USD 16,750 every year. Moreover, the implementation of smart devices and technical advancements such as the use of AI & data analytics are fuelling the market growth.
The acceptance rate of insulin delivery devices in Asian nations, such as China and India, is more. Factors such as rising awareness about diabetes care and a developing healthcare landscape are accountable for the higher adoption of these devices in the APAC nations. Additionally, the growth in healthcare expenditure has intended to an upsurge in the acceptance of technologically advanced products in countries such as India & China and is projected to boost the complete market growth.
Key Companies Insights
To stay competitive in the global market, players are using new strategies such as new product development, mergers and acquisitions, joint ventures, and geographic expansions.
Some of the key players operating in the global diabetes care products market include:
· Abbott
· F. Hoffmann-La Roche AG
· Johnson & Johnson
· Dexcom
· Medtronic
· Novo Nordisk
· Ascensia Diabetes Care
· AgaMatrix
· Bionime Corporation
· Omnipod
· Medisana
· Trivia
· Rossmax International Ltd.
· Other players
Some of the Recent Developments:
· In 2021, Medtronic received a CE mark for the InPen smart insulin pen and Guardian 4 sensor for better diabetes management.
· In 2019, Novo Nordisk collaborated with Abbott to integrate its prefilled and durable connected pens directly into the FreeStyle Libre system.
Segments
By Monitoring Device
· Self-monitoring Blood Glucose Device
o Glucometers
o Test Strips
o Lancets
· Continuous Glucose Monitoring Devices
o Sensors and Durables
o Receivers and Transmitters
By Management Device
· Insulin Pump
o Insulin Pump Monitors
o Insulin Pump Reservoirs
o Insulin Infusion Sets
· Insulin Syringes
· Cartridges in Reusable pens
· Insulin Disposable Pens
· Jet Injectors
By Distribution Channel
· Hospital Pharmacies
· Retail Pharmacies
· Online Pharmacies
By Geography
· North America
o U.S.
o Canada
o Mexico
· Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
· Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
· Latin America
o Brazil
o Argentina
o Colombia
· MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Reasons to Purchase Diabetes Care Products Market Report• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1.1 Product Overview and Scope of Diabetes Care Products
1.2 Diabetes Care Products Segment by Type
1.2.1 Global Diabetes Care Products Sales Growth Rate Comparison by Type (2022-2030)
1.2.2 Diabetes Testing Products
1.2.3 Insulin Pump
1.2.4 Diabetic Accessories
1.2.5 Diabetic Foot Care
1.2.6 Insulin Syringes
1.3 Diabetes Care Products Segment by Application
1.3.1 Diabetes Care Products Sales Comparison by Application: (2022-2030)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Diabetes Care Products Market Size Estimates and Forecasts
1.4.1 Global Diabetes Care Products Revenue 2016-2030
1.4.2 Global Diabetes Care Products Sales 2016-2030
1.4.3 Diabetes Care Products Market Size by Region: 2016 Versus 2022 Versus 2030
2 Diabetes Care Products Market Competition by Manufacturers
2.1 Global Diabetes Care Products Sales Market Share by Manufacturers (2016-2021)
2.2 Global Diabetes Care Products Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Diabetes Care Products Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Diabetes Care Products Manufacturing Sites, Area Served, Product Type
2.5 Diabetes Care Products Market Competitive Situation and Trends
2.5.1 Diabetes Care Products Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Diabetes Care Products Players Market Share by Revenue
2.5.3 Global Diabetes Care Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetes Care Products Retrospective Market Scenario by Region
3.1 Global Diabetes Care Products Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Diabetes Care Products Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Diabetes Care Products Market Facts & Figures by Country
3.3.1 North America Diabetes Care Products Sales by Country
3.3.2 North America Diabetes Care Products Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Diabetes Care Products Market Facts & Figures by Country
3.4.1 Europe Diabetes Care Products Sales by Country
3.4.2 Europe Diabetes Care Products Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Diabetes Care Products Market Facts & Figures by Region
3.5.1 Asia Pacific Diabetes Care Products Sales by Region
3.5.2 Asia Pacific Diabetes Care Products Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Diabetes Care Products Market Facts & Figures by Country
3.6.1 Latin America Diabetes Care Products Sales by Country
3.6.2 Latin America Diabetes Care Products Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Diabetes Care Products Market Facts & Figures by Country
3.7.1 Middle East and Africa Diabetes Care Products Sales by Country
3.7.2 Middle East and Africa Diabetes Care Products Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Diabetes Care Products Historic Market Analysis by Type
4.1 Global Diabetes Care Products Sales Market Share by Type (2016-2021)
4.2 Global Diabetes Care Products Revenue Market Share by Type (2016-2021)
4.3 Global Diabetes Care Products Price by Type (2016-2021)
5 Global Diabetes Care Products Historic Market Analysis by Application
5.1 Global Diabetes Care Products Sales Market Share by Application (2016-2021)
5.2 Global Diabetes Care Products Revenue Market Share by Application (2016-2021)
5.3 Global Diabetes Care Products Price by Application (2016-2021)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Corporation Information
6.1.2 BD Description and Business Overview
6.1.3 BD Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.1.4 BD Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bayer Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Abbott Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 B. Braun
6.4.1 B. Braun Corporation Information
6.4.2 B. Braun Description and Business Overview
6.4.3 B. Braun Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.4.4 B. Braun Product Portfolio
6.4.5 B. Braun Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Corporation Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Medtronic Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 Tandem Diabetes Care
6.6.1 Tandem Diabetes Care Corporation Information
6.6.2 Tandem Diabetes Care Description and Business Overview
6.6.3 Tandem Diabetes Care Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Tandem Diabetes Care Product Portfolio
6.6.5 Tandem Diabetes Care Recent Developments/Updates
6.7 Insulet Corporation
6.6.1 Insulet Corporation Corporation Information
6.6.2 Insulet Corporation Description and Business Overview
6.6.3 Insulet Corporation Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Insulet Corporation Product Portfolio
6.7.5 Insulet Corporation Recent Developments/Updates
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Roche Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 J&J
6.9.1 J&J Corporation Information
6.9.2 J&J Description and Business Overview
6.9.3 J&J Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.9.4 J&J Product Portfolio
6.9.5 J&J Recent Developments/Updates
6.10 ARKRAY Inc
6.10.1 ARKRAY Inc Corporation Information
6.10.2 ARKRAY Inc Description and Business Overview
6.10.3 ARKRAY Inc Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.10.4 ARKRAY Inc Product Portfolio
6.10.5 ARKRAY Inc Recent Developments/Updates
6.11 Ypsomed
6.11.1 Ypsomed Corporation Information
6.11.2 Ypsomed Diabetes Care Products Description and Business Overview
6.11.3 Ypsomed Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Ypsomed Product Portfolio
6.11.5 Ypsomed Recent Developments/Updates
6.12 Sannuo
6.12.1 Sannuo Corporation Information
6.12.2 Sannuo Diabetes Care Products Description and Business Overview
6.12.3 Sannuo Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Sannuo Product Portfolio
6.12.5 Sannuo Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi Diabetes Care Products Description and Business Overview
6.13.3 Sanofi Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Sanofi Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
6.14 I-sens
6.14.1 I-sens Corporation Information
6.14.2 I-sens Diabetes Care Products Description and Business Overview
6.14.3 I-sens Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.14.4 I-sens Product Portfolio
6.14.5 I-sens Recent Developments/Updates
6.15 Abbott
6.15.1 Abbott Corporation Information
6.15.2 Abbott Diabetes Care Products Description and Business Overview
6.15.3 Abbott Diabetes Care Products Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Abbott Product Portfolio
6.15.5 Abbott Recent Developments/Updates
7 Diabetes Care Products Manufacturing Cost Analysis
7.1 Diabetes Care Products Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Diabetes Care Products
7.4 Diabetes Care Products Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Diabetes Care Products Distributors List
8.3 Diabetes Care Products Customers
9 Diabetes Care Products Market Dynamics
9.1 Diabetes Care Products Industry Trends
9.2 Diabetes Care Products Growth Drivers
9.3 Diabetes Care Products Market Challenges
9.4 Diabetes Care Products Market Restraints
10 Global Market Forecast
10.1 Diabetes Care Products Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Diabetes Care Products by Type (2022-2030)
10.1.2 Global Forecasted Revenue of Diabetes Care Products by Type (2022-2030)
10.2 Diabetes Care Products Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Diabetes Care Products by Application (2022-2030)
10.2.2 Global Forecasted Revenue of Diabetes Care Products by Application (2022-2030)
10.3 Diabetes Care Products Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Diabetes Care Products by Region (2022-2030)
10.3.2 Global Forecasted Revenue of Diabetes Care Products by Region (2022-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI